A 32-year-old woman with Graves' disease is being treated with antithyroid drugs. Regarding the pharmacological management of hyperthyroidism, all of the following are correct EXCEPT:

Explanation

## Pharmacological Management of Graves' Disease ### Role of Iodine Solutions **Key Point:** Iodine (Lugol's solution, saturated solution of potassium iodide [SSKI]) is NOT suitable for long-term monotherapy. It is used ONLY as a short-term adjunct: - **Onset**: Rapid (24–48 hours) — blocks thyroid hormone release - **Duration**: 10–14 days maximum before escape phenomenon occurs - **Mechanism**: Inhibits thyroid peroxidase AND suppresses TSH-mediated thyroid growth - **Escape**: Prolonged use leads to escape from the inhibitory effect; thyroid hormone levels rise again **Warning:** Using iodine as sole long-term therapy will fail. It must be combined with antithyroid drugs or used pre-operatively (7–10 days before thyroidectomy). ### Comprehensive Management Algorithm ```mermaid flowchart TD A[Graves' Disease Diagnosis]:::outcome --> B[Initiate PTU or Methimazole]:::action B --> C[Add Beta-blocker for symptom relief]:::action C --> D{Severe/Thyroid storm?}:::decision D -->|Yes| E[Add Iodine solution for 10-14 days]:::action D -->|No| F[Continue antithyroid drug alone] E --> G[Antithyroid drug monotherapy continues] F --> G G --> H[Treat for 12-18 months]:::action H --> I{Remission achieved?}:::decision I -->|Yes| J[Discontinue, monitor TSH]:::outcome I -->|No| K[Consider thyroidectomy or RAI]:::action ``` ### Comparative Roles of Agents | Agent | Role | Duration | Mechanism | | --- | --- | --- | --- | | **PTU/Methimazole** | Definitive therapy | 12–18 months | Block hormone synthesis | | **Iodine (Lugol's)** | Short-term adjunct only | 10–14 days max | Block hormone release | | **Beta-blockers** | Symptomatic relief | As needed | Block adrenergic effects | | **Propranolol** | Symptomatic relief + peripheral conversion block | As needed | Beta-blockade + T₄→T₃ inhibition | ### Why Propranolol is Preferred Among Beta-Blockers **Clinical Pearl:** Propranolol (and to a lesser extent, atenolol) has an ADDITIONAL advantage: - **Inhibits type 1 deiodinase** → blocks peripheral conversion of T₄ to T₃ - This provides dual benefit: symptom relief + modest reduction in circulating T₃ - Other beta-blockers (e.g., metoprolol) lack this property ### Duration of Antithyroid Drug Therapy **High-Yield:** PTU or methimazole must be continued for **12–18 months** to allow: - Gradual remission of Graves' disease (spontaneous remission rate ~30–50%) - Suppression of autoimmune thyroid response - Gradual reduction in TSH receptor antibodies After 12–18 months: - If remission occurs (TSH normal, free T₄ normal off medication): discontinue, monitor TSH - If relapse occurs: consider thyroidectomy or radioactive iodine (RAI) **Mnemonic:** **IODINE = Immediate, Only short-term, Does NOT work long-term, Induces escape** (why iodine fails as monotherapy) [cite:Harrison 21e Ch 397; KD Tripathi 8e Ch 41]